Nitric Oxide‐Releasing Catheters with Phenol‐Amine Catalytic Coatings for Improved Anti‐Inflammatory Performance
Advanced Healthcare Materials · 2025-12 · 14 (31)
DOI: 10.1002/adhm.202500457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 29.08.2025. Verfasst von Qingqing Fan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Australian Centre for Nanomedicine (ACN), The University of New South Wales, Sydney, NSW, 2052, Australia. Hauptthemen laut MEDLINE: Nitric Oxide, Anti-Inflammatory Agents, Coated Materials, Biocompatible, Catheters. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Royal Society, British Heart Foundation.
Abstract (Originalsprache)
Nitric oxide (NO) is a signaling molecule critical for vasodilation, bacterial inhibition, and inflammation modulation, making it valuable for medical devices, such as catheters. However, existing NO‐releasing catheters face challenges, including maintaining stable NO release over time and complex manufacturing processes. In this study, a robust nanocoating made from tannic acid (TA) and selenocystamine (SeCA) is presented, designed to catalytically generate NO from S ‐nitrosoglutathione in the presence of glutathione. Surface characterization techniques confirmed successful coating formation, with optimal NO generation achieved at a 1:4 TA:SeCA molar ratio. The coated catheters maintained over 96% viability of human coronary artery smooth muscle cells (HCASMCs) after 72 h. It has been demonstrated that the modified catheters significantly increased endogenous NO production in HCASMCs from intracellular S ‐nitrosothiols, highlighting their potential to support vascular function. The coating sustained NO release at 7 × 10 −10 mol cm −2 min −1 for at least 3 days, exceeding the typical release rate of healthy endothelium. Notably, the coating effectively reduced pro‐inflammatory cytokine (TNF‐α and IL‐6) production in RAW 264.7 macrophages upon lipopolysaccharide stimulation, demonstrating anti‐inflammatory effects. This material‐driven approach simplifies NO delivery and offers an effective strategy to enhance catheter efficacy to support vascular function and minimize inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering and Australian Centre for Nanomedicine (ACN), The University of New South Wales, Sydney, NSW, 2052, Australia.
- Department of Chemical Engineering, The University of Melbourne, Parkville, VIC, 3010, Australia.
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation (BHF) Centre of Research Excellence, University of Oxford, Headington, Oxford, OX3 7BN, UK.
ORCID-Profile: Rona Chandrawati
Förderung
- National Health and Medical Research Council
- Royal Society
- British Heart Foundation
Zitieren
APA
Fan, Q., Geng, S., Tabish, T. A., Lin, K., Yin, Y., Adzlan, S. N. A., Mazur, F., & Chandrawati, R. (2025). Nitric Oxide‐Releasing Catheters with Phenol‐Amine Catalytic Coatings for Improved Anti‐Inflammatory Performance. Advanced Healthcare Materials, 14(31). https://doi.org/10.1002/adhm.202500457
Vancouver
Fan Q, Geng S, Tabish TA, Lin K, Yin Y, Adzlan SNA, et al. Nitric Oxide‐Releasing Catheters with Phenol‐Amine Catalytic Coatings for Improved Anti‐Inflammatory Performance. Advanced Healthcare Materials. 2025;14(31). doi:10.1002/adhm.202500457
BibTeX
@article{Fan2025,
author = {Fan, Qingqing and Geng, Shu and Tabish, Tanveer A and Lin, Kang and Yin, Yiyi and Adzlan, Siti Nur Asyura and Mazur, Federico and Chandrawati, Rona},
title = {Nitric Oxide‐Releasing Catheters with Phenol‐Amine Catalytic Coatings for Improved Anti‐Inflammatory Performance},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {31},
doi = {10.1002/adhm.202500457}
}
EUVIMED